Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Enterprise ValueMarket Capitalization

RAPT Therapeutics (RAPT) Asset Utilization Ratio: 2020-2022

Historic Asset Utilization Ratio for Therapeutics (RAPT) over the last 1 years, with Jun 2022 value amounting to 0.02.

  • Therapeutics' Asset Utilization Ratio fell 45.67% to 0.02 in Q2 2022 from the same period last year, while for Jun 2022 it was 0.02, marking a year-over-year decrease of 45.67%. This contributed to the annual value of 0.01 for FY2022, which is 72.64% down from last year.
  • As of Q2 2022, Therapeutics' Asset Utilization Ratio stood at 0.02, which was down 5.21% from 0.02 recorded in Q1 2022.
  • In the past 5 years, Therapeutics' Asset Utilization Ratio ranged from a high of 0.05 in Q1 2021 and a low of 0.02 during Q2 2022.
  • Moreover, its 3-year median value for Asset Utilization Ratio was 0.02 (2021), whereas its average is 0.03.
  • Data for Therapeutics' Asset Utilization Ratio shows a maximum YoY plummeted of 64.68% (in 2022) over the last 5 years.
  • Over the past 3 years, Therapeutics' Asset Utilization Ratio (Quarterly) stood at 0.04 in 2020, then plummeted by 54.94% to 0.02 in 2021, then slumped by 45.67% to 0.02 in 2022.
  • Its Asset Utilization Ratio was 0.02 in Q2 2022, compared to 0.02 in Q1 2022 and 0.02 in Q4 2021.